Skip to content

Sotera Health SHC Additional Paid-In Capital

Additional Paid-In Capital at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$1.97B-0.5%
Fortive logo
FortiveFTV
$4.23B+3.8%
Balchem logo
BalchemBCPC
$89.54M-48.6%
Natera, Inc. logo
Natera, Inc.NTRA
$4.64B+19.6%
Oklo logo
OkloOKLO
$2.91B+606%
Labcorp Holdings logo
Labcorp HoldingsLH
$0-100%

Other financials

Income statement

See full
Revenue$280.0M+10.0%
Gross profit$147.1M+8.6%
Operating income$87.1M-16.2%
Net income$26.6M+301%
EPS (diluted)$0.09+280%

Balance sheet

See full
Cash & equivalents$314.1M+3.2%
Total debt$2.3B-3.2%
Total equity$622.5M+50.3%
Total assets$3.2B+4.5%

Cash flow

See full
Operating cash flow$29.4M-47.0%
CapEx$46.2M+132%
Free cash flow-$16.7M-147%

Valuation

See full
Market cap$4.51B+23.4%
Enterprise value$6.47B+12.8%
P/E38.3×-109×
P/S3.8×+0.5×

Profitability

See full
Gross margin55.3%+0.1pp
Operating margin27%+0.7pp
Net margin9.9%+7.7pp
FCF margin8.1%

Returns & leverage

See full
Return on equity22.7%+16.8pp
Debt / equity3.6×-2.0×
Current ratio2.8×+0.4×

Where this comes from

Reported directly by Sotera Health in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Sotera Health’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sotera Health's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sotera Health's additional paid-in capital?
Sotera Health (SHC) reported additional paid-in capital of $1.26B in Q1 2026.
How has Sotera Health's additional paid-in capital changed year-over-year?
Sotera Health's additional paid-in capital increased by 1.5% year-over-year, from $1.24B to $1.26B.
What is the long-term trend for Sotera Health's additional paid-in capital?
Over 5 years (2020 to 2025), Sotera Health's additional paid-in capital has grown at a 1.6% compound annual growth rate (CAGR), from $1.17B to $1.26B.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.